Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5928746 | American Heart Journal | 2013 | 9 Pages |
Abstract
Consistent with previous literature, upstream treatment with eptifibatide was associated with improved outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients treated with PCI; however, a nonsignificant interaction term precludes a definite conclusion.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Akshay MD MHS, Jennifer A. MS, Yuliya PhD, Robert P. MD, Frans MD, Gilles MD, Paul W. MD, Pierluigi MD, PhD, MHS, C. Michael MD, Robert M. MD, Robert A. MD, L. Kristin MD, MHS,